Status:
COMPLETED
High Dose Nimodipine Treatment Adjunct - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
Washington D.C. Veterans Affairs Medical Center
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
22-45 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient...
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
May 1 1998
Trial Type :
INTERVENTIONAL
End Date :
April 1 2000
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000332
Start Date
May 1 1998
End Date
April 1 2000
Last Update
February 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington DC VA
Washington D.C., District of Columbia, United States, 20422